Vertex Pharmaceuticals Inc (VRTX) Financials
Key financial figures for Vertex Pharmaceuticals Inc (Q2 2026).
- Revenue
- $3.3B
- Net Income
- $1.1B
- EPS
- $4.34
- Total Assets
- $27.4B
- Operating Cash Flow
- $1.1B
Full income statement, balance sheet, and cash flow for Vertex Pharmaceuticals Inc on SentiSense.